Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-07-30

FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Pentasa (mesalamine) from Takeda Pharmaceuticals America, Inc., updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PENTASA (MESALAMINE)

Snippet

SUPPL AP for PENTASA (MESALAMINE)